On 2024-08-09, ACASTI PHARM-TS (V.APO) announced earnings per share of -0.33 for the fiscal quarter ending 2024-06-30, beating the average analyst estimate of -0.38.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-08-09 | 2024-06-30 | -0.38 | -0.33 |
| 2024-06-21 | 2024-03-31 | -0.48 | -0.24 |
| 2024-02-12 | 2023-12-31 | -0.41 | -0.29 |
| 2023-11-13 | 2023-09-30 | -- | -0.26 |
| 2023-08-11 | 2023-06-30 | -0.83 | -0.46 |
| 2023-06-23 | 2023-03-31 | -1.02 | -0.42 |
| 2023-02-14 | 2022-12-31 | -1.02 | -0.72 |
| 2022-11-14 | 2022-09-30 | -- | -0.84 |
| 2022-08-11 | 2022-06-30 | -- | -0.78 |
| 2022-06-21 | 2022-03-31 | -1.02 | -0.30 |
| 2022-02-14 | 2021-12-31 | -0.60 | -0.66 |
| 2021-11-10 | 2021-09-30 | -- | 0.24 |
| 2021-08-12 | 2021-06-30 | -- | -0.96 |
| 2021-06-22 | 2021-03-31 | -- | -1.92 |
| 2021-02-09 | 2020-12-31 | -- | -1.44 |
| 2020-11-16 | 2020-09-30 | -4.32 | -2.88 |
| 2020-08-13 | 2020-06-30 | -4.32 | -3.36 |
| 2020-06-29 | 2020-03-31 | -6.24 | -2.88 |
| 2020-02-14 | 2019-12-31 | -8.16 | -8.64 |
| 2019-11-13 | 2019-09-30 | -6.24 | -4.80 |
| 2019-08-14 | 2019-06-30 | -7.20 | -7.20 |
| 2019-06-26 | 2019-03-31 | -7.20 | -10.56 |
| 2019-02-14 | 2018-12-31 | -4.80 | -3.36 |
| 2018-11-14 | 2018-09-30 | -13.44 | -12.96 |
| 2018-08-14 | 2018-06-30 | -- | -11.04 |
| 2018-06-27 | 2018-03-31 | -- | -59.03 |
| 2018-02-13 | 2017-12-31 | -- | -19.20 |
| 2017-11-13 | 2017-09-30 | -- | -14.88 |
| 2017-08-14 | 2017-05-31 | -- | -9.12 |
| 2017-01-12 | 2016-11-30 | -- | -10.56 |
| 2016-10-11 | 2016-08-31 | -- | -10.56 |
| 2016-07-11 | 2016-05-31 | -- | -13.92 |
| 2016-05-25 | 2016-02-29 | -- | -8.64 |
| 2016-01-12 | 2015-11-30 | -- | -10.08 |
| 2015-10-14 | 2015-08-31 | -- | -4.80 |
| 2015-07-13 | 2015-05-31 | -- | -4.80 |
| 2015-05-27 | 2015-02-28 | -- | -9.60 |
| 2015-01-13 | 2014-11-30 | -- | 14.40 |